12.47 USD
↗ 0.00 (0.00%)AT CLOSE (11:59 AM EDT)
NovoCure Limited Ordinary Shares
NVCRNASDAQ • USD
12.42
↘ 0.05 (0.40%)
POST MARKET (AS OF 07:49 PM EDT)
Post Market
AS OF 07:49 PM EDT
12.42
↘ 0.05 (0.40%)
Market: CLOSED
Open?$12.69
High?$12.83
Low?$12.31
Prev. Close?$12.47
Volume?781.9K
Avg. Volume?1.2M
VWAP?$12.43
Rel. Volume?0.68x
Bid / Ask
Bid?$12.29 × 1.0K
Ask?$12.55 × 100
Spread?$0.26
Midpoint?$12.42
Valuation & Ratios
Market Cap?1.4B
Shares Out?115.8M
Float?92.1M
Float %?82.3%
P/E Ratio?N/A
P/B Ratio?4.24
EPS?-$1.18
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?2.85Strong
Quick Ratio?2.67Strong
Cash Ratio?0.42Low
Debt/Equity?0.57Moderate
ValuationATTRACTIVELY VALUED
Score92/100
P/E?N/A▾
P/B?4.24FAIR▾
P/S?2.20CHEAP▾
P/FCF?N/A▾
EV/EBITDA?-11.1CHEAP▾
EV/Sales?2.36CHEAP▾
Returns & Efficiency
ROE?-40.0%WEAK▾
ROA?-16.9%WEAK▾
Cash Flow & Enterprise
FCF?$-75679000
Enterprise Value?$1.5B
Fundamentals ratios updated end of day
xxx
Related Companies
Loading...
News
Profile
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
Employees
1.6K
Market Cap
1.4B
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Website
Listed
2015-10-02
Address
NO. 4 THE FORUM
ST. HELIER,
Phone: 44 (0)15 3475 6700
ST. HELIER,
Phone: 44 (0)15 3475 6700